- Home
- NXTC vs BLIN Comparison
NXTC vs BLIN Comparison
Compare NXTC & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- BLIN
- Stock Information
- Founded
- NXTC 2015
- BLIN 2000
- Country
- NXTC United States
- BLIN United States
- Employees
- NXTC N/A
- BLIN N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- BLIN EDP Services
- Sector
- NXTC Health Care
- BLIN Technology
- Exchange
- NXTC Nasdaq
- BLIN Nasdaq
- Market Cap
- NXTC 21.6M
- BLIN 20.6M
- IPO Year
- NXTC 2019
- BLIN 2007
- Fundamental
- Price
- NXTC $0.72
- BLIN $1.57
- Analyst Decision
- NXTC Strong Buy
- BLIN Strong Buy
- Analyst Count
- NXTC 2
- BLIN 1
- Target Price
- NXTC $4.00
- BLIN $4.62
- AVG Volume (30 Days)
- NXTC 61.8K
- BLIN 136.1K
- Earning Date
- NXTC 03-20-2025
- BLIN 02-13-2025
- Dividend Yield
- NXTC N/A
- BLIN N/A
- EPS Growth
- NXTC N/A
- BLIN N/A
- EPS
- NXTC N/A
- BLIN N/A
- Revenue
- NXTC N/A
- BLIN $15,394,000.00
- Revenue This Year
- NXTC N/A
- BLIN $7.51
- Revenue Next Year
- NXTC N/A
- BLIN $6.57
- P/E Ratio
- NXTC N/A
- BLIN N/A
- Revenue Growth
- NXTC N/A
- BLIN N/A
- 52 Week Low
- NXTC $0.66
- BLIN $0.76
- 52 Week High
- NXTC $2.57
- BLIN $2.80
- Technical
- Relative Strength Index (RSI)
- NXTC 40.34
- BLIN 40.34
- Support Level
- NXTC $0.66
- BLIN $1.65
- Resistance Level
- NXTC $0.79
- BLIN $1.83
- Average True Range (ATR)
- NXTC 0.06
- BLIN 0.19
- MACD
- NXTC 0.00
- BLIN -0.05
- Stochastic Oscillator
- NXTC 42.21
- BLIN 5.74
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.